Stay updated on Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Sign up to get notified when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T05:57:06.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to include a new multicenter phase II study evaluating the combination of denosumab and nivolumab for stage IV non-small-cell lung cancer patients with bone metastases, along with details about the study's inclusion and exclusion criteria. Additionally, the principal investigator's name has been added.
    Difference
    47%
    Check dated 2025-04-16T16:54:01.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 13, 2025.
    Difference
    0.3%
    Check dated 2025-04-09T11:19:40.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:52:56.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T21:55:42.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page has been updated to reflect the current status of the DENIVOS study, including new dates and the removal of outdated information regarding its status and last updates.
    Difference
    3%
    Check dated 2025-02-17T17:39:33.000Z thumbnail image

Stay in the know with updates to Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.